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Abstract
Background: Cancer-related pain is common and under-treated. This article describes a study designed to test the
effectiveness of a theory-driven, patient-centered coaching intervention to improve cancer pain processes and outcomes.
Methods/Design: The Cancer Health Empowerment for Living without Pain (Ca-HELP) Study is an American Cancer
Society sponsored randomized trial conducted in Sacramento, California. A total of 265 cancer patients with at least
moderate pain severity (Worst Pain Numerical Analog Score >=4 out of 10) or pain-related impairment (Likert score
>= 3 out of 5) were randomly assigned to receive tailored education and coaching (TEC) or educationally-enhanced usual
care (EUC); 258 received at least one follow-up assessment. The TEC intervention is based on social-cognitive theory
and consists of 6 components (assess, correct, teach, prepare, rehearse, portray). Both interventions were delivered
over approximately 30 minutes just prior to a scheduled oncology visit. The majority of visits (56%) were audio-recorded
for later communication coding. Follow-up data including outcomes related to pain severity and impairment, self-efficacy
for pain control and for patient-physician communication, functional status and well-being, and anxiety were collected at
2, 6, and 12 weeks.
Discussion: Building on social cognitive theory and pilot work, this study aims to test the hypothesis that a brief, tailored
patient activation intervention will promote better cancer pain care and outcomes. Analyses will focus on the effects of
the experimental intervention on pain severity and impairment (primary outcomes); self-efficacy and quality of life
(secondary outcomes); and relationships among processes and outcomes of cancer pain care. If this model of coaching
by lay health educators proves successful, it could potentially be implemented widely at modest cost.
Trial Registration: [Clinical Trials Identifier: NCT00283166]
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Background
An estimated 90% of patients with cancer experience at
least moderate pain at some point in their illness, and
42% of patients receive inadequate palliation [1] Aside
from impairing quality of life, uncontrolled pain can con-
tribute to depression, increase the likelihood of suicide,
and decrease patient acceptance of potentially beneficial
therapy[1] Barriers to effective pain control reside with
health care systems, physicians and patients[2,3] While
efforts to address system- and provider-level barriers must
continue, patients and their families represent an attrac-
tive target for interventions because they stand to gain the
most from effective pain management and because acti-
vated patients have considerable influence on physician
behavior[4,5] The Ca-HELP (Cancer Health Empower-
ment for Living without Pain) Study is a randomized con-
trolled trial of a brief patient activation intervention. This
article describes the rationale and conceptual model
underlying the study, the Tailored Education and Coach-
ing (TEC) protocol, the design and administration of the
study, and the planned analytic approach. Results from
the study are expected to be published in 2010.
In a series of articles published in the late 1980's, Green-
field, Kaplan, and colleagues showed that expanding
patients' involvement in care can improve patient out-
comes[4,6] In the cancer domain, at least six separate, ran-
domized controlled trials have shown that educational
interventions with components emphasizing self-care or
activation can improve care of cancer-related pain [7-12]
All of these studies delivered various combinations of
information and support. In general, more intensive inter-
ventions involving human interaction and support were
associated with larger effects on pain-related processes
and outcomes. However, no studies explicitly tested indi-
vidually tailored interventions to enhance pain-related
communication with the treating physician as well as pain
self-management. In addition, several practical and theo-
retical issues have limited the introduction of these inter-
ventions into practice: the interventions have frequently
required highly specialized personnel, were often applied
to highly selected subgroups, made few attempts to meas-
ure mediating or moderating variables, were not general-
izable to clinically and demographically heterogeneous
populations, and generally emphasized patient education
over than participation in care.
In a pilot evaluation of the intervention described in this
article, Oliver et al randomized English-speaking adults
with cancer and moderate pain to a 20-minute TEC ses-
sion (n = 34) or to a control group (n = 33)[13] At base-
line, there were no significant differences between
experimental and control groups in terms of average pain,
functional impairment due to pain, pain frequency, or
pain-related knowledge. However, average pain at follow-
up improved significantly more among experimental
patients (p = .014). Subsequent work by Kalauokalani et
al. showed that benefits of the intervention were concen-
trated among ethnic minorities, leading to a reduction in
health disparities[14]
The current study evaluates a brief, patient-centered, the-
ory-driven intervention that, if shown to be effective,
could be widely disseminated. The TEC intervention
developed for this study is rooted in Social Cognitive The-
ory (SCT) as developed by Bandura.[15] This theory posits
that behavior change and maintenance are largely a func-
tion of expectations about one's ability to engage in or
execute the behavior[16] In Bandura's conceptualization,
self-efficacy is derived from four sources: previous per-
formance, vicarious experiences, verbal persuasion, and
mood. The first three sources impact self-efficacy directly.
The TEC intervention creates the expectation of success by
simulating successful interactions with the physician
through role play, describing the success of other patients,
and persuading the patient of the benefits of greater par-
ticipation in care.
Bandura's notion of self-efficacy is task specific. We
hypothesized that two forms of self-efficacy may be ger-
mane to cancer pain management. Pain management self-
efficacy is confidence in the ability to achieve control over
one's pain. Communication self-efficacy is confidence in the
ability to communicate effectively about pain with one's
physician. These two forms of self-efficacy may mediate
pain relief via separate pathways. As depicted in Figure 1,
pain management self-efficacy may lead to a greater sense
of pain-related mastery and control, which in turn pro-
motes less pain, anxiety, and functional impairment[13]
Communication self-efficacy leads theoretically to more
assertive interactions with the physician, more effective
clinical interventions (e.g., provision of stronger analge-
sics), and better outcomes.
Effective pain self-management requires the patient to
apply a complex set of skills that involve monitoring,
Ca-HELP Conceptual model Figure 1
Ca-HELP Conceptual model.
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medicating (for chronic and breakthrough pain), antici-
pating (side effects), and communicating with the treating
physician. SCT predicts that patients with greater self-effi-
cacy for these behaviors will have a higher likelihood of
actually performing them. The theory finds empirical sup-
port in a meta-analysis of psychosocial interventions
among cancer patients[17] In that study, Graves showed
that interventions with more SCT components had larger
effect sizes than interventions with fewer SCT compo-
nents.
This article describes the design and implementation of
the Cancer Health Empowerment for Living without Pain
(Ca-HELP) Study.
Methods/Design
Study design
The study was designed as a randomized controlled trial
comparing TEC to educationally-enhanced usual care
(EUC). The unit of randomization is the individual
patient. The choice of design reflects several considera-
tions. We used EUC rather than usual care as the compa-
rator in order to control for the effects of time,
information-giving and companionship. Thus, any
improvement in observed pain outcomes would owe to
the effects of activation-coaching over and above what
might be accomplished by having an empathetic lay per-
son provide educational materials and engage in support-
ive conversation. We chose to randomize individual
patients rather than physicians or systems because: 1) the
intervention is posited to exert its effects primarily by
affecting patient knowledge, attitudes, self-efficacy, and
behaviors; and 2) based on the known difficulties in con-
sistently modifying physician behavior [18,19], spill-over
effects (changes in physician behavior as a result of seeing
multiple intervention patients) were expected to be mini-
mal. The overall study design is depicted in Figure 2.
Selection of study sites and physicians
Cancer care physicians were recruited from three health
systems (UC Davis Cancer Center; Kaiser-Permanente Sac-
ramento/Roseville; and the VA Northern California
Health System) and one private practice, all in Northern
California. Medical, radiation, and (after March 2008)
gynecological oncologists (including both staff physicians
and clinical fellows) were deemed eligible if they saw
patients at one of the participating sites and were in clini-
cal practice at least 20% time (i.e., at least 1 full day per
week). Physicians gave blanket consent to contact all their
eligible patients, or in several instances, selected patients
only. Among the 49 participating physicians, 23 (47%)
authorized audiorecording of the index study visit. Physi-
cians were offered feedback on the outcomes of their own
patients compared with the aggregate results but received
no monetary compensation.
Patient eligibility, recruitment, consent, and 
randomization
Ethical approval was obtained by the Institutional Review
Boards of University of California, Davis and the Kaiser
Foundation Research Institute. Patients eligible for enroll-
ment in the study included all cognitively intact, English-
speaking adults obtaining care (active treatment or sur-
veillance) from participating oncologists for selected solid
tumors and who reported more than minimal cancer-
related pain. "Cancer-related pain" was defined as "pain
that you would bring to the attention of your cancer doc-
tor" (regardless of the actual etiology). More than mini-
mal pain was defined as a score of 4 or greater (on a scale
of 0-10) for "worst pain past two weeks" or pain that dur-
ing the same period interfered at least moderately with
function. Specific inclusion and exclusion criteria are pre-
sented in Table 1.
Study design Figure 2
Study design.
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Potentially eligible patients were identified with the assist-
ance of participating oncologists, who provided compu-
ter-generated lists of patients who had been seen within
the past 3 months (UCDMC) or were scheduled to be seen
within the next two months (Kaiser, VA, and private prac-
tice). Personalized letters were prepared notifying patients
of the aims of the study and requesting assent to contact
them by phone. A pre-paid post card was enclosed with
the letter; patients wishing to avoid telephone contact
returned the card and were not contacted further. After a
minimum of three weeks, patients not returning the opt-
out postcard were contacted by telephone, screened for
eligibility, and invited to participate in the study. Verbally
consenting patients were mailed a study enrollment
packet containing a cover letter and a written consent
form. Usually within three weeks (but always prior to the
next oncology visit), a study representative conducted an
Enrollment Interview by phone. The purpose of the
Enrollment Interview was to collect baseline information
on pain, other cancer symptoms, psychological distress,
health related quality of life, adherence, and self-efficacy.
By collecting the majority of baseline data by telephone
prior to the index visit, we limited respondent burden and
were able to focus the index visit on delivery of the inter-
vention rather than collection of data. Patients were
promised a total of $80 compensation: $50 for complet-
ing the intervention and $10 for the 2-, 6-, and 12-week
follow-up telephone surveys, respectively.
At the conclusion of the Enrollment Interview, patients
were randomized to the TEC or EUC groups using a
blocked-randomization scheme to assure balanced
assignment within physicians. For each physician in the
study, a separate sequence of random 1's (TEC group) and
0's (EUC group) was generated for use in assigning
patients. To preserve blinding, treatment assignment (0/
1) was encoded as a set of 3-digit numbers maintained by
the study statistician. The encoded sequences were printed
on two adhesive labels, one affixed to the patient's Enroll-
ment Interview form and another to the Tracking Sheet in
each patient's Case Report File (CRF). The CRF served as
the patient's study record and included a log of all con-
tacts with research staff, all completed telephone surveys,
the survey booklet completed by the patient on the date of
the intervention, and documentation of payment for
study participation.
Visit procedures
Patients were asked to arrive one hour prior to the next
scheduled oncology appointment (referred to subse-
quently as the "index visit"). Upon arrival at the clinic
waiting area, study participants were greeted by a trained
Health Educator (HE), escorted to a quiet space, and given
the opportunity to sign the Patient Bill of Rights, IRB-
approved Consent Form, and the HIPAA Release Form.
All patients then completed the Pre-visit/Pre-Intervention
Questionnaire. This form was self-administered, but the
HE was available to provide assistance if needed. At this
juncture, patients received their assigned intervention
(TEC or EUC). For quality control and training purposes,
all interventions were audio-taped. Following the inter-
vention (which lasted 20-40 minutes), patients com-
pleted another self-administered instrument, the Pre-
visit/Post-Intervention Questionnaire. If the attending
oncologist and patient had provided prior consent to be
audiotaped (77/130 or 59% of TEC visits, 71/135 or 53%
of EUC visits), the HE placed a small audiorecording
device in the exam room. Immediately after the visit,
patients were intercepted by the HE and asked to com-
plete the Post-visit Questionnaire. They were thanked for
Table 1: Patient inclusion and exclusion criteria.
Inclusion Criteria Exclusion Criteria
Seen or scheduled to be seen at participating facility Major surgical procedure scheduled within six weeks
Age 18 to 80 Enrolled in hospice
Diagnosis of locally advanced or disseminated lung, breast, prostate, 
head & neck, esophageal, colorectal, or gynecologic cancers*
Followed by pain management service 
(more than one visit made or scheduled)
English speaking Already contacted for study
Recent worst pain (past two weeks) reported to be 4 or higher (on a 
scale of 0 to 10) OR pain in past two weeks reported to have interfered 
with normal daily activities at least moderately (at least 3 on a 5-point 
scale).
Difficulty thinking or expressing himself
Unable to receive and/or complete mailed enrollment materials
*Patients with pancreatic cancer were included initially, but this diagnosis was removed from the list of eligible cancers on June 1, 2007 upon the 
recommendation of the Data Safety and Monitoring Board.BMC Cancer 2009, 9:319 http://www.biomedcentral.com/1471-2407/9/319
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their participation and reminded that they would receive
their first follow-up phone call in two weeks.
Description of experimental and control interventions
The TEC intervention was based on the model previously
described by Oliver et al[13] This approach uses a specific
assessment of each patient's learning needs, goals, and
values to develop a set of individualized messages and
skill-building exercises designed to increase self-efficacy,
enhance patient-physician communication, and improve
care of cancer-related pain. HEs were intensively trained
over approximately 80 hours to elicit patients' values;
deliver clear, plain-spoken messages; and to be sensitive
to cultural differences that may influence how different
patients respond to their illness and to the intervention.
They were reconvened at intervals of 3-6 months to assure
continued fidelity to study procedures. For this study, we
revised the TEC Manual using a 6-step program: Assess,
Correct, Teach, Plan, Rehearse, Portray (ACT-PReP). Com-
ponents of the program include:
(1) Assessment of current knowledge, attitudes, and prefer-
ences (values). As an initial step in the TEC intervention,
the HE reviews information supplied by the patient as part
of the baseline interview, focusing on current symptoms,
pain-related knowledge and attitudes, and self-efficacy
expectations. Using a set of questions found in the TEC
Training and Resource Manual, the HE also helps the
patient to clarify his or her major pain-related concerns
and treatment-preferences.
(2) Correction of misconceptions about cancer pain con-
trol. Patients frequently harbor false or exaggerated beliefs
that can interfere with effective management of cancer-
related pain[2,20,21] Using patients' responses to the
Short Barriers Questionnaire,[22] the HE reviews specific
pain-related misconceptions and offers an algorithm-
based corrective. For example, if a patient were to believe
that effective pain medicine should be withheld until the
pain is so bad the patient "really needs it,", then the HE
would respond that pain is easier to control when treated
early, and while the dose might need to increase over
time, there is no reason to hold treatment in reserve.
(3)  Teaching  of relevant concepts. Although TEC is
designed primarily to enhance self-efficacy, the interven-
tion also transmits knowledge in two domains. The first
domain is pain self-management. Patients are taught that
pain per se can be harmful to health; that pain is easier to
prevent than to treat (which is why long-acting, around-
the-clock, oral pain medicines are beneficial); that combi-
nations of medicines are often required for optimal relief
(e.g., short- and long-acting analgesics); that most analge-
sic side effects can be managed effectively (through a com-
bination of adjuvant medications and lifestyle
adjustments); and that non-pharmacologic approaches
such as music, relaxation, meditation, or distraction are
sometimes useful adjuncts. The second domain is patient-
physician communication. Patients are taught that that it is
important to bring pain-related symptoms to the physi-
cian's attention and that most doctors are open to a nego-
tiated approach to care. Patients are also counseled about
the possibility of physician resistance to assertive behav-
iors and coached regarding specific strategies for breaking
through such resistance.
(4)  Planning  (identifying goals, matching strategies to
goals). In this step, which is at the heart of the TEC inter-
vention, the HE encourages the patient to identify goals,
frame them so they are achievable, and plot strategies to
gain the doctor's help in accomplishing them. For exam-
ple, a patient might express the desire to sleep through the
night without pain. The HE would ask the patient to for-
mulate, write down, and practice questions to ask the phy-
sician what would help achieve the goal (e.g., "What pain
medication can I take that will last through the night?").
(5) Rehearsal using role play exercises. In this step, the HE
asks the patient to participate in role-playing exercises
where the patient rehearses question-asking and negotia-
tion behaviors. As a start, the educator asks the patient to
practice asking the physician three (personally relevant)
questions about pain. If the patient is able to complete
this task successfully, the educator will ask him/her to
repeat the exercise, this time introducing physician resist-
ance (e.g., "I don't typically like to prescribe triplicate
medications"; "I'd like to concentrate on getting your
blood count up"; "Let's get some tests and see what's
going on"). The patient will be encouraged to practice
until comfortable with the behaviors or until the session
ends.
(6) Portrayal of learned skills. In this segment, the patient
has the opportunity to apply new skills immediately dur-
ing the scheduled oncology visit. If the patient is success-
ful in doing so, SCT predicts that self-efficacy will be
enhanced, theoretically leading to even greater pain self-
management and participation in care, which in turn
leads to greater self-efficacy.[15]
Patients randomly assigned to the EUC group were
greeted in the same manner and asked to complete the
same survey instruments as patients assigned to the TEC
intervention. The HE provided both groups of patients
with a copy of the booklet, Pain Control: A Guide for
Patients with Cancer and Their Families, published by the
National Cancer Institute.[20] With EUC group patients,
the HE verbally reviewed selected points in the booklet,
emphasizing key aspects of pain-related knowledge,
including: 1) pain is controllable with modern treat-BMC Cancer 2009, 9:319 http://www.biomedcentral.com/1471-2407/9/319
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ments; 2) pain medications have side effects that can be
controlled; and 3) cancer patients rarely experience addic-
tion. The main difference between TEC and the EUC inter-
ventions is that the latter promotes acquisition of
knowledge in the pain domain but does not correct spe-
cific misconceptions, teach in the communication
domain, facilitate planning, or encourage rehearsal of
new skills. As a result, it was hypothesized that the TEC
intervention would produce greater gains in self-efficacy
and improved outcomes.
Administration of measures
Table 2 describes the key measures, including constructs
assessed and time points for assessment. The enrollment
interview and the 2-, 6-, and 12-week follow-up interviews
were conducted by phone. The Pre-visit Pre-Intervention
Table 2: Description and administration of measures
Domain Measure Screening/
Enrollment
Pre-
intervention
Post-
intervention, 
Previsit
Post-
visit
2-week 
Follow-up
6-week 
Follow-up
12-week 
Follow-up
Demographics Age, race, sex, 
education, 
marital status
X
Average Pain Numerical 
Analog Scale 
(0-10)
XXX X X X X
Worst Pain Numerical 
Analog Scale 
(0-10)
XXX X X X X
Pain Severity Mean of Average 
and Worst Pain
XXX X X X X
Pain 
Impairment
MOS Pain 
Impairment 
Scale
XX X X X
Anxiety HADS Anxiety 
Subscale
XX X
Functional 
Status and 
Well-being
SF-12 X X
Depression PHQ-2 (not 
administered 
until Spring 
2007)
XX X X
Pain Beliefs Brief Pain 
Barriers 
Questionnaire
XX
Pain-Related 
Self-Efficacy
Derived from 
Anderson
XXX X X X X
General 
Adherence
MOS General 
Adherence
XX X
Communicatio
n Self-Efficacy
Maly X X X X X X X
Analgesic 
Therapy
Chart review XBMC Cancer 2009, 9:319 http://www.biomedcentral.com/1471-2407/9/319
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Survey, the Pre-visit Post-Intervention Survey, and the
Post-visit Survey were self-administered with assistance
from the HE available as needed. Demographic characteris-
tics were assessed using administrative records, the screen-
ing interview, and the enrollment interview. Average pain
was assessed with a single numerical analog scale, with 0
representing no pain on average over the past two weeks
and 10 representing the worst pain imaginable. Worst pain
in past two weeks was assessed using the same 0 to 10
numerical analog scale. (In the pre-intervention, pre-
intervention/pre-visit, and post-visit interviews, average
and worst pain were measured using a visual analog scale
with 0-10 numerical anchors.)Pain impairment was meas-
ured using the MOS Pain Impairment Scale[23]Anxiety
was tapped by the anxiety subscale of the Hospital Anxiety
and Depression Scale [24], while functional status and
well-being was assessed with the SF-12.[25]Pain-related
knowledge and beliefs were measured using 11 items
selected from the Brief Pain Barriers Questionnaire, focus-
ing on the controllability of pain, perceptions of physi-
cians' attitudes towards pain, and concern about side
effects of analgesics.[21]Self-efficacy for controlling pain and
for communicating about pain with the cancer doctor were
assessed based on scales developed by Anderson et al. and
Maly et al. [26], respectively. Clinical data, including can-
cer diagnosis, cancer stage, current use of cytoreductive
therapies, and analgesic prescribing, were obtained via
chart review using a standardized abstraction form. Inter-
rater reliability (kappas) for abstraction of clinical data
averaged 0.94 [range: 0.84, 1.0].
For the subsample of visits that were audiorecorded (n =
148), two sets of communication measures were used, dis-
course coding of active patient participation and observer
ratings of physician's informativeness and facilitative
communication [27-30] Using a previously validated cod-
ing scheme,[28,30] active patient participation was coded
independently by two coders who identified three catego-
ries of utterances: asking questions, assertiveness (offering
opinions, stating preferences, making a request), and
expressing concerns (worries, fears, negative feelings). The
intraclass reliability coefficient (ICC) for the sum of active
communication behaviors, established on subset of 15
consultations, was 0.78. Two coders also listened to each
interaction and rated the physicians' informativeness on
5-point Likert scales[27,29] and the physicians' participa-
tory decision-making on 10 point scales[31,32] The ICC
was 0.80 for informativeness and 0.72 for participatory
decision making.
Sample size determination
A prospective sample size calculation was performed dur-
ing the protocol-writing stage. It aimed to determine a tar-
get sample size that would provide 80% power for two-
tailed testing (at a type-1 error rate of 5%) of each of the
key study hypotheses concerned with between arm differ-
ences in regression-adjusted follow-up outcome meas-
ures. The investigators concluded that an effect size of
0.33 units of standard deviation of the unadjusted out-
come distribution was appropriately modest for a rela-
tively inexpensive pain control intervention. Under
plausible assumptions about the net variance reduction
achievable through particular features of our study design
(e.g. within-physician randomization and repeated meas-
ures regression data analysis)[33] and about the rate of
attrition for enrolled participants after study baseline, a
sample size of 230 was targeted as being sufficient to
achieve the required effective sample size of 284. A power
analysis conducted independently by the Data Safety and
Monitoring Board early in the data collection phase of the
study resulted in the recommendation that the target sam-
ple size be increased to 275. The targeted sample size of
275 provides the desired statistical power under more
conservative assumptions about the net effects of sample
attrition (up to 15% of patients lost to follow-up at 6
weeks), variance reduction via regression adjustment (no
more than 25%) and variance inflation of up to 10% aris-
ing from between-physician heterogeneity (e.g. clustering
effects) in treatment effects.
Data Safety and Monitoring Board (DSMB)
The first patient was enrolled on 10/30/2006. A DSMB
was established shortly after project launch and met sev-
eral times during the two-year data collection period.
Members included a clinician-epidemiologist, an attorney
affiliated with a non-profit medical research and policy
foundation, and a senior academic statistician who served
as the Board's chair. Based on the Board's recommenda-
tions issued in June 2007, project staff amended the study
protocol to limit the number of enrolled patients per phy-
sician to a maximum of 40; increase the target sample size
from 230 to 275; and develop procedures for dealing with
(and if necessary, referring) patients who were disturbed
by the screening phone call because they were no longer
in active treatment for their cancer. In the subsequent
project year, the Board evaluated randomization proce-
dures and requested additional analyses following the rev-
elation that among the first 100 enrollees, intervention
group patients were significantly older than control group
patients. The Board found no irregularities and attributed
the age imbalance to chance.
Patient accrual and study flow
Of 3720 patients sent a recruitment letter, 3413 were
excluded due to returning an opt-out postcard (n = 1011);
inability to contact by phone despite repeated calls (n =
1015); or ineligility at the time of screening (n = 1182), at
enrollment (n = 202) or during follow-up (i.e., 3 patients
with pancreatic cancer were dropped from the study on
the advice of the DSMB) (Figure 3). The remainingBMC Cancer 2009, 9:319 http://www.biomedcentral.com/1471-2407/9/319
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patients (n = 307) were randomized, and 265 received the
allocated treatment (130 received the experimental [TEC]
intervention, 135 received the control intervention).
Planned analytic approach
In subsequent publications, we will report results pertain-
ing to intervention effects and putative mechanisms. Pri-
mary outcomes will include: 1) pain severity at two-
weeks, measured as the mean of average and worst pain
and 2) pain-related impairment at 2 weeks. To test for
attenuation, the effect of the intervention on pain severity
and impairment at latter follow-up occasions (i.e. at 6 and
12 weeks) will be reported as secondary outcomes. Addi-
tional secondary analyses will estimate effects of the inter-
vention on average pain; self-efficacy for pain control; and
self-efficacy for communication with the physician.
Finally, exploratory analyses will assess the interaction
between the intervention and minority race, as suggested
by previous work[14] The primary estimates of the effects
of the intervention on each of these outcomes will come
from generalized linear regression analyses, following the
intent-to-treat principle. All analyses will adjust for the
Flow of subjects in trial Figure 3
Flow of subjects in trial.
3720 assessed for eligibility 
3413 excluded  
Reasons:  returned opt-out postcard (n = 1011) 
                  unable to contact (n = 1015) 
                  screened out (n = 1182) 
                  ineligible at enrollment (n = 202) 
                  pancreatic cancer (n=3) 
307 eligible and randomized  
157 allocated to TEC 
Experimental Intervention 
130 received Experimental Intervention  
27 did not receive Experimental 
intervention  
  Reasons: deceased (n=1)  
                 too sick (n=5)      
                 cancelled or unable to    
                 schedule the intervention 
                (n=21)
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15 did not receive Control intervention  
  Reasons: deceased (n=1)  
                 too sick (n=3) 
                 cancelled or unable to 
                 schedule the intervention 
                 (n=11) 
F
o
l
l
o
w
 
u
p
 
4 lost to follow up  
  Reasons: deceased (n=1)  
                 unable to contact (n=3) 
Discontinued intervention (n = 0) 
3 lost to follow up  
  Reason: unable to contact (n=3) 
Discontinued intervention (n = 0) 
A
n
a
l
y
s
i
s
  126 analyzed 
We analyzed if at least 1 follow-up was completed.    
31 excluded from analysis 
  Reasons: did not receive  
                  intervention (n=27) 
                 lost to follow up (n=4) 
132 analyzed 
We analyzed if at least 1 follow-up was completed 
18 excluded from analysis  
  Reasons: did not receive  
                  intervention (n=15) 
                 lost to follow up (n=3) BMC Cancer 2009, 9:319 http://www.biomedcentral.com/1471-2407/9/319
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nesting of observations within physician, and, where
appropriate, the nesting of repeated observations within
patient, with nesting variables treated as random effects.
Discussion
The Ca-HELP Study is a multi-site randomized trial of a
patient-centered coaching intervention designed to
improve cancer pain care and outcomes. Important fea-
tures of the study include its focus on ambulatory patients
with cancer-related pain recruited from several health care
systems, broad inclusion criteria, strong theoretical foun-
dations based on SCT, randomization at the patient level,
and tracking of multiple outcomes at 2, 6, and 12 weeks.
Use of multiple methods (survey, audiorecording) and
multiple measures (pain, quality of life, self-efficacy, com-
munication) favors a comprehensive assessment of a
complex behavioral intervention. We have demonstrated
the ability to train lay HEs with high fidelity and recruit,
enroll, and track large numbers of patients with cancer-
related pain.
Major challenges encountered during implementation of
the study included recruiting and training HEs, complying
with multiple Institutional Review Boards (IRBs), main-
taining fidelity of the intervention, and dealing with
patient fatigue and distress during advanced stages of ill-
ness. Seeking generalizability, we initially recruited a rela-
tively large cohort of part-time lay HEs but found turnover
was reduced by relying on a smaller number of more com-
mitted personnel. Recruitment of patients was slowed by
IRB requirements that patients identified as appropriate
candidates by their oncologists be allowed the opportu-
nity to opt out by mail before being contacted by the study
staff. However, these requirements were an artefact of the
study and would not apply should the intervention be
incorporated into routine clinical care. Fidelity to the
ACT-PReP paradigm was ensured by universal monitoring
and intermittent review and feedback. Finally, while the
vast majority of patients expressed gratitude for being able
to participate in the study, some had trouble with lengthy
telephone follow-up instruments, which occasionally
required interruption of the interviews with call-back at a
more convenient time.
In summary, the Ca-HELP Study has successfully trained
lay HEs to deliver a theory-driven intervention designed
to improve an important clinical target. Subsequent anal-
yses will focus on the effects of the experimental interven-
tion on pain, self-efficacy, and quality of life and examine
relationships among processes and outcomes of cancer
pain care.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
RLK generated the idea, obtained funding, and orches-
trated implementation of the protocol. DJT contributed to
the design and statistical analysis plan. RLS planned the
clinical conversation analysis. DK contributed specialty
expertise in pain management. TG coordinated imple-
mentation of the study at the HMO site. TW coordinated
implementation at the academic site. CS and DED man-
aged the project. LL served as lead health educator. PF con-
tributed to all aspects of design and analytic planning. All
authors read and approved the final version of the manu-
script.
Acknowledgements
This study was funded by a Research Scholars Grant in Cancer Control 
from the American Cancer Society (Dr. Kravitz). Dr. Kravitz was also sup-
ported during the project period by a Mid-Career Research and Mentoring 
Award (MH72756) from the National Institute of Mental Health. The 
authors would like to thank Jennifer Wright Oliver, Kate Lorig, and Diana 
Wilkie for their contributions to development of this protocol.
References
1. Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B,
et al.: National Institutes of Health State-of-the-Science Con-
ference Statement: Symptom Management in Cancer: Pain,
Depression, and Fatigue, July 15-17, 2002.  Journal of the National
Cancer Institute 2003, 95(15):1110-7.
2. Cleeland CS: Barriers to the management of cancer pain.
Oncology (Huntington) 1987, 1(2 Suppl):19-26.
3. Ward SE, Goldberg N, Miller-McCauley V, Mueller C, Nolan A, Paw-
lik-Plank D, et al.: Patient-related barriers to management of
cancer pain.  Pain 1993, 52(3):319-24.
4. Greenfield S, Kaplan S, Ware JE Jr: Expanding patient involve-
ment in care. Effects on patient outcomes.  Annals of internal
medicine 1985, 102(4):520-8.
5. Kravitz RL, Bell RA, Azari R, Kelly-Reif S, Krupat E, Thom DH: Direct
observation of requests for clinical services in office practice:
what do patients want and do they get it?  Arch Intern Med 2003,
163(14):1673-81.
6. Kaplan SH, Greenfield S, Ware JE Jr: Assessing theeffects of phy-
sician-patient interactions on the outcomes of chronic dis-
ease.  Medical care 1989, 27(3 Suppl):S110-27.
7. Clotfelter CE: The effect of an educational intervention on
decreasing pain intensity in elderly people with cancer.  Oncol
Nurs Forum 1999, 26(1):27-33.
8. de Wit R, van Dam F, Loonstra S, Zandbelt L, van Buuren A, Heijden
K van der, et al.: Improving the quality of pain treatment by a
tailored pain education programme for cancer patients in
chronic pain.  European journal of pain (London, England) 2001,
5(3):241-56.
9. de Wit R, van Dam F, Zandbelt L, van Buuren A, Heijden K van der,
Leenhouts G, et al.: A pain education program for chronic can-
cer pain patients: follow-up results from a randomized con-
trolled trial.  Pain 1997, 73(1):55-69.
10. Miaskowski C, Dodd M, West C, Schumacher K, Paul SM, Tripathy D,
et al.: Randomized clinical trial of the effectiveness of a self-
care intervention to improve cancer pain management.  J Clin
Oncol 2004, 22(9):1713-20.
11. Rimer B, Levy MH, Keintz MK, Fox L, Engstrom PF, MacElwee N:
Enhancing cancer pain control regimens through patient
education.  Patient Educ Couns 1987, 10(3):267-77.
12. Wilkie DJ, Williams AR, Grevstad P, Mekwa J: Coaching persons
with lung cancer to report sensory pain. Literature review
and pilot study findings.  Cancer Nurs 1995, 18(1):7-15.
13. Oliver JW, Kravitz RL, Kaplan SH, Meyers FJ: Individualized
patient education and coaching to improve pain control
among cancer outpatients.  J Clin Oncol 2001, 19(8):2206-12.
14. Kalauokalani D, Franks P, Oliver JW, Meyers FJ, Kravitz RL: Can
patient coaching reduce racial/ethnic disparities in cancerPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cancer 2009, 9:319 http://www.biomedcentral.com/1471-2407/9/319
Page 10 of 10
(page number not for citation purposes)
pain control? Secondary analysis of a randomized controlled
trial.  Pain Med 2007, 8(1):17-24.
15. Bandura A: Self-efficacy: Toward a unifying theory ofbehavio-
ral change.  Psychol Rev 1977, 84:191-215.
16. Strecher V, Devellis B, Becker M, Rosenstock I: The roleof self-effi-
cacy in achieving health behavior change.  Health Education
Quarterly 1986, 13:73-91.
17. Graves K: Social cognitive theory and cancer patients'quality
of life: a meta-analysis of psychosocial intervention compo-
nents.  Health Psychology 2003, 22:210-9.
18. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA,
et al.: Why don't physicians follow clinical practice guidelines?
A framework for improvement.  Jama 1999, 282(15):1458-65.
19. Grimshaw JM, Eccles MP, Walker AE, Thomas RE: Changing physi-
cians' behavior: what works and thoughts on getting more
things to work. The Journal of continuing education in the
health professions.  Fall 2002, 22(4):237-43.
20. Department of Health and Human Services: Pain Control: A Guide
for People with Cancer and Their Families.  Institute NC, edi-
tor.: US DHHS; 2003. 
21. Gunnarsdottir S, Donovan HS, Serlin RC, Voge C, Ward S: Patient-
related barriers to pain management: the Barriers Ques-
tionnaire II (BQ-II).  Pain 2002, 99(3):385-96.
22. Wells N, Johnson RL, Wujcik D: Development of a short version
of the Barriers Questionnaire.  J Pain Symptom Manage 1998,
15(5):294-8.
23. Sherbourne C: Pain Measures.  In Measuring Functioning and Well-
Being: The Medical Outcomes Study Approach Edited by: Stewart AL,
Ware JE Jr. Durham, NC: Duke University Press; 1992:220-34. 
24. Snaith RP: The Hospital Anxiety and Depression Scale.  Health
and quality of life outcomes 2003, 1:29.
25. Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health
Survey: construction of scales and preliminary tests of relia-
bility and validity.  Medical care 1996, 34(3):220-33.
26. Maly RC, Frank JC, Marshall GN, DiMatteo MR, Reuben DB: Per-
ceived efficacy in patient-physician interactions (PEPPI): val-
idation of an instrument in older persons.  Journal of the
American Geriatrics Society 1998, 46(7):889-94.
27. Gordon H, Street R Jr, Sharf B, Souchek J: Racialdifferences in doc-
tors' information-giving and patients' participation.  Cancer
2006, 107:1313-20.
28. Street RJ: Information-giving in medical consultations: the
influence of patients' communicative styles and personal
characteristics.  Social Science & Medicine 1991, 32(5):541-8.
29. Street R Jr, Gordon H, Haidet P: Physicians' communication and
perceptions of patients: Is it how they look, how they talk, or
is it just the doctor?  Social Science & Medicine 2007, 65:586-98.
30. Ward M, Sundaramurthy S, Lotstein D, Bush T, Neuwelt C, Street R
Jr: Participatory patient-physician communication and mor-
bidity in patients with systemic lupus erythematosus.  Arthritis
Rheum 2003, 49:810-8.
31. Kaplan SH, Gandek B, Greenfield S, Rogers W, Ware JE: Patient and
visit characteristics related to physicians' participatory deci-
sion-making style. Results from the Medical Outcomes
Study.  Medical care 1995, 33(12):1176-87.
32. Kaplan SH, Greenfield S, Gandek B, Rogers WH, Ware JE Jr: Char-
acteristics of physicians with participatory decision-making
styles.  Annals of internal medicine 1996, 124(5):497-504.
33. Hsieh FY, Lavori PW, Cohen HJ, Feussner JR: An overview of var-
iance inflation factors for sample-size calculation.  Eval Health
Prof 2003, 26(3):239-57.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2407/9/319/pre
pub